Notification of a Public Meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission), 24995-24996 [2017-11230]

Download as PDF nlaroche on DSK30NT082PROD with NOTICES Federal Register / Vol. 82, No. 103 / Wednesday, May 31, 2017 / Notices available at: http://www.phmsa.dot.gov/ hazmat/regs/international under Upcoming Events. This information will also be posted on OSHA’s Hazard Communication Web site on the international tab at: https:// www.osha.gov/dsg/hazcom/hazcom_ international.html#meeting-notice. FOR FURTHER INFORMATION CONTACT: At the Department of Transportation, please contact Mr. Steven Webb or Mr. Aaron Wiener, Office of Hazardous Materials Safety, Department of Transportation, Washington, DC 20590, telephone: (202) 366–8553. At the Department of Labor, please contact Ms. Maureen Ruskin, OSHA Directorate of Standards and Guidance, Department of Labor, Washington DC 20210, telephone: (202) 693–1950, email: ruskin.maureen@dol.gov. SUPPLEMENTARY INFORMATION: The OSHA Meeting: OSHA is hosting an open informal public meeting of the U.S. Interagency GHS Coordinating Group to provide interested groups and individuals with an update on GHSrelated issues and an opportunity to express their views orally and in writing for consideration in developing U.S. Government positions for the upcoming UNSCEGHS meeting. General topics on the agenda include: • Review of Working papers • Correspondence Group updates • Regulatory Cooperation Council (RCC) Update Information on the work of the UNSCEGHS including meeting agendas, reports, and documents from previous sessions, can be found on the United Nations Economic Commission for Europe (UNECE) Transport Division Web site located at the following web address: http://www.unece.org/trans/ danger/publi/ghs/ghs_welcome_e.html. The UNSCEGHS bases its decisions on Working Papers. The Working Papers for the 33rd session of the UNSCEGHS are located at: https://www.unece.org/ trans/main/dgdb/dgsubc4/c42017.html. Informal Papers submitted to the UNSCEGHS provide information for the Sub-committee and are used either as a mechanism to provide information to the Sub-committee or as the basis for future Working Papers. Informal Papers for the 33nd session of the UNSCEGHS are located at: http://www.unece.org/ trans/main/dgdb/dgsubc4/c4inf32.html. In addition to participating at the Public meeting, interested parties may submit comments on the Working and Informal Papers for the 33rd session of the UNSCEGHS to the docket established for International/Globally Harmonized System (GHS) efforts at http://www.regulations.gov, Docket No. OSHA–2016–0005. VerDate Sep<11>2014 14:54 May 30, 2017 Jkt 241001 The PHMSA Meeting: The Federal Register notice and additional detailed information relating to PHMSA’s public meeting will be available upon publication at: http:// www.regulations.gov/ (Docket No.PHMSA–2017–0037, Notice No. 2017–02), and on the PHMSA Web site at: http://www.phmsa.dot.gov/hazmat/ regs/international. PHMSA will host the meeting to gain input from the public concerning proposals submitted to the UNSCETDG for the 21st Revised Edition of the United Nations Recommendations on the Transport of Dangerous Goods Model Regulations, which may be implemented into relevant domestic, regional, and international regulations from January 1, 2021. During this meeting, PHMSA is also soliciting input relative to preparing for the 51th session of the UNSCE TDG as well as potential new work items which may be considered for inclusion in its international agenda. Copies of working documents, informal documents, and the meeting agenda may be obtained from the United Nations Transport Division’s Web site at: https://www.unece.org/trans/main/ dgdb/dgsubc3/c32017.html. http:// www.unece.org/trans/danger/ danger.html. Authority and Signature This document was prepared under the direction of Dorothy Dougherty, Deputy Assistant Secretary of Labor for Occupational Safety and Health, U.S. Department of Labor, pursuant to sections 4, 6, and 8 of the Occupational Safety and Health Act of 1970 (29 U.S.C. 653, 655, 657), and Secretary’s Order 1– 2012 (77 FR 3912), (Jan. 25, 2012). Signed at Washington, DC, on May 18, 2017. Dorothy Dougherty, Deputy Assistant Secretary of Labor for Occupational Safety and Health. [FR Doc. 2017–11170 Filed 5–30–17; 8:45 am] BILLING CODE 4510–26–P EXECUTIVE OFFICE OF THE PRESIDENT Office of National Drug Control Policy Notification of a Public Meeting of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Commission) Office of National Drug Control Policy (ONDCP). ACTION: Notice of meeting. AGENCY: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 24995 ONDCP announces the first meeting of the President’s Commission on Combating Drug Addiction and the Opioid Crisis to advance the Commission’s work on drug issues and the opioid crisis per Executive Order 13784. The first meeting will consist of statements to the Commission from invited nonprofit organizations regarding drug issues followed by discussion of the issues raised. DATES: The first Commission meeting will be held on Friday June 16, 2017 from 12:30 p.m. until approximately 2:30 p.m. (Eastern Time). ADDRESSES: The meeting will be held at the Eisenhower Executive Office Building, Room 350, in the Executive Office of the President in Washington, DC. It will be open to the public through livestreaming on https:// www.whitehouse.gov/live. FOR FURTHER INFORMATION CONTACT: General information concerning the Commission and its meetings can be found on ONDCP’s Web site at https:// www.whitehouse.gov/ondcp/presidentscommission. Any member of the public who wishes to obtain information about the Commission or its meetings that is not already on ONDCP’s Web site or who wishes to submit written comments for the Commission’s consideration may contact Michael Passante, Designated Federal Officer (DFO) via email at commission@ondcp.eop.gov or telephone at (202) 395–6709. Please note that ONDCP may post such written comments publicly on our Web site, including names and contact information that are submitted. There will not be oral comments from the public at the meeting. Requests to accommodate disabilities with respect to livestreaming or otherwise should also be sent to that email address, preferably at least 10 days prior to the meeting to allow time for processing. SUPPLEMENTARY INFORMATION: The Commission was established in accordance with E.O. 13784 of March 29, 2017, the Commission’s charter, and the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App. 2, to obtain advice and recommendations for the President regarding drug issues. The Executive Order, charter, and information on the Members of the Commission are available on ONDCP’s Web site. The Commission will function solely as an advisory body and will make recommendations regarding policies and practices for combating drug addiction with particular focus on the current opioid crisis in the United States. The Commission’s final report is due October 1, 2017 unless there is an SUMMARY: E:\FR\FM\31MYN1.SGM 31MYN1 24996 Federal Register / Vol. 82, No. 103 / Wednesday, May 31, 2017 / Notices extension. Per E.O. 13784, the Commission shall: a. Identify and describe the existing Federal funding used to combat drug addiction and the opioid crisis; b. assess the availability and accessibility of drug addiction treatment services and overdose reversal throughout the country and identify areas that are underserved; c. identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, collaboration between State and Federal officials, and the use and effectiveness of State prescription drug monitoring programs; d. review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids; e. identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and effectiveness, and make recommendations for improving these programs; and; f. make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis. Dated: May 25, 2017. Michael Passante, Acting General Counsel, Designated Federal Officer. [FR Doc. 2017–11230 Filed 5–30–17; 8:45 am] BILLING CODE 3280–F5–P NUCLEAR REGULATORY COMMISSION [NRC–2017–0130] Qualification of Safety-Related Vented Lead-Acid Storage Batteries for Nuclear Power Plants Nuclear Regulatory Commission. ACTION: Draft regulatory guide; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment draft regulatory guide (DG), DG–1338, ‘‘Qualification of SafetyRelated Vented Lead-Acid Storage Batteries for Nuclear Power Plants.’’ DG–1338 is proposed revision 1 of regulatory guide (RG) 1.158, ‘‘Qualification of Safety-Related Lead Storage Batteries for Nuclear Power Plants’’ dated February 1989. DG–1338 endorses (with clarifying regulatory positions) the Institute of Electrical and Electronics Engineers (IEEE) Standard (Std.) 535–2013, ‘‘IEEE Standard for nlaroche on DSK30NT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 14:54 May 30, 2017 Jkt 241001 Qualification of Class 1E Vented Lead Acid Storage Batteries for Nuclear Power Generating Stations.’’ IEEE 535– 2013 contains procedures for qualifying batteries with duty cycles of less than 8 hours and batteries with duty cycles longer than 8 hours. DATES: Submit comments by July 31, 2017. Comments received after this date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date. Although a time limit is given, comments and suggestions in connection with items for inclusion in guides currently being developed or improvements in all published guides are encouraged at any time. ADDRESSES: You may submit comments by any of the following methods: • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID: NRC–2017–0130. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Cindy Bladey, Office of Administration, Mail Stop: TWFN–08C22, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Lilliana Ramadan, telephone: 301–415– 2463, email: Lilliana.Ramadan@ nrc.Gov, or Mark Orr, telephone: 301– 415–6003, email: Mark.Orr@nrc.gov. Both are staff of the Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2017– 0130 when contacting the NRC about the availability of information regarding this action. You may obtain publicallyavailable information related to this action, by any of the following methods: • Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC–2017–0130. • NRC’s Agencywide Documents Access and Management System PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The DG is electronically available in ADAMS under Accession No. ML16337A005. The regulatory analysis for this DG is available in ADAMS under Accession No. ML16340A112. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. B. Submitting Comments Please include Docket ID NRC–2017– 0130 in your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC posts all comment submissions at http:// www.regulations.gov as well as enters the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. II. Additional Information The NRC is issuing for public comment a DG in the NRC’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public information regarding methods that are acceptable to the NRC staff for implementing specific parts of the NRC’s regulations, techniques that the staff uses in evaluating specific issues or postulated events, and data that the staff needs in its review of applications for permits and licenses. The DG, entitled ‘‘Qualification of Safety-Related Vented Lead-Acid Storage Batteries for Nuclear Power E:\FR\FM\31MYN1.SGM 31MYN1

Agencies

[Federal Register Volume 82, Number 103 (Wednesday, May 31, 2017)]
[Notices]
[Pages 24995-24996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11230]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Notification of a Public Meeting of the President's Commission on 
Combating Drug Addiction and the Opioid Crisis (Commission)

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: ONDCP announces the first meeting of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis to advance 
the Commission's work on drug issues and the opioid crisis per 
Executive Order 13784. The first meeting will consist of statements to 
the Commission from invited nonprofit organizations regarding drug 
issues followed by discussion of the issues raised.

DATES: The first Commission meeting will be held on Friday June 16, 
2017 from 12:30 p.m. until approximately 2:30 p.m. (Eastern Time).

ADDRESSES: The meeting will be held at the Eisenhower Executive Office 
Building, Room 350, in the Executive Office of the President in 
Washington, DC. It will be open to the public through livestreaming on 
https://www.whitehouse.gov/live.

FOR FURTHER INFORMATION CONTACT: General information concerning the 
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the 
public who wishes to obtain information about the Commission or its 
meetings that is not already on ONDCP's Web site or who wishes to 
submit written comments for the Commission's consideration may contact 
Michael Passante, Designated Federal Officer (DFO) via email at 
commission@ondcp.eop.gov or telephone at (202) 395-6709. Please note 
that ONDCP may post such written comments publicly on our Web site, 
including names and contact information that are submitted. There will 
not be oral comments from the public at the meeting. Requests to 
accommodate disabilities with respect to livestreaming or otherwise 
should also be sent to that email address, preferably at least 10 days 
prior to the meeting to allow time for processing.

SUPPLEMENTARY INFORMATION: The Commission was established in accordance 
with E.O. 13784 of March 29, 2017, the Commission's charter, and the 
provisions of the Federal Advisory Committee Act (FACA), as amended, 5 
U.S.C. App. 2, to obtain advice and recommendations for the President 
regarding drug issues. The Executive Order, charter, and information on 
the Members of the Commission are available on ONDCP's Web site. The 
Commission will function solely as an advisory body and will make 
recommendations regarding policies and practices for combating drug 
addiction with particular focus on the current opioid crisis in the 
United States. The Commission's final report is due October 1, 2017 
unless there is an

[[Page 24996]]

extension. Per E.O. 13784, the Commission shall:
    a. Identify and describe the existing Federal funding used to 
combat drug addiction and the opioid crisis;
    b. assess the availability and accessibility of drug addiction 
treatment services and overdose reversal throughout the country and 
identify areas that are underserved;
    c. identify and report on best practices for addiction prevention, 
including healthcare provider education and evaluation of prescription 
practices, collaboration between State and Federal officials, and the 
use and effectiveness of State prescription drug monitoring programs;
    d. review the literature evaluating the effectiveness of 
educational messages for youth and adults with respect to prescription 
and illicit opioids;
    e. identify and evaluate existing Federal programs to prevent and 
treat drug addiction for their scope and effectiveness, and make 
recommendations for improving these programs; and;
    f. make recommendations to the President for improving the Federal 
response to drug addiction and the opioid crisis.

    Dated: May 25, 2017.
Michael Passante,
Acting General Counsel, Designated Federal Officer.
[FR Doc. 2017-11230 Filed 5-30-17; 8:45 am]
 BILLING CODE 3280-F5-P